2,6-bis(3,5-dimethylpyrazoyl)pyridine iron(II) chloride | 526191-01-5

• 英文名称: 2,6-bis(3,5-dimethylpyrazoyl)pyridine iron(II) chloride
• CAS: 526191-01-5
• 化学式: C₁₅H₁₇Cl₂FeN₅
• 分子量: 394.086
• InChiKey: UDTKMSMJGFXDAB-UHFFFAOYSA-L

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为反应物：
  描述：

  乙腈 、 2,6-bis(3,5-dimethylpyrazoyl)pyridine iron(II) chloride 以 甲苯 、 乙腈 为溶剂， 生成 FeCl2(2,6-bis(3,5-dimethyl-N-pyrazolyl)pyridine)*CH3CN
  参考文献：
  名称：

  Synthesis and structural characterization of iron(II) derivatives of heterocyclic tridentate amines

  摘要：

  Compounds of general formula FeX2(L) {L=2,6-bis(3,5-dimethyl-N-pyrazolyl)pyridine, C15H17N5; bis[3,5-dimethyl-N-pyrazolyl)methyl]-isopropylamine, C15H25N5; bis(benzimidazol-2-yl-methyl)amine, C16H15N5, 1,3-bis(benzimidazolyl)propane, C17H16N4; bis(benzimidazolyl-2-methyl)ether, C16H14N4O; bis(benzimidazolyl-2-methyl)thioether, C16H14N4S} have been synthesized by reacting the amine with Fe4Cl8(THF)(6) or FeI2(CO)(4) in toluene. The complexes FeCl2(Cl15H17N5).MeCN and FeCl2(C16H15N5)(MeOH) have been characterized by single crystal X-ray diffraction together with the parent triamines, C15H17N5 and C16H15N5, for comparison. The reaction of FeI2(CO)(4) with bis(benzimidazolyl-2-methyl)thioether, C16H14N4S, led to the product of partial carbonyl substitution Fel(2)(CO)(2)(C16H14N4S). (C) 2002 Elsevier Science B.V. All rights reserved.

  DOI：

  10.1016/s0020-1693(02)01304-x
• 作为产物：
  描述：

  2,6-二(3,5-二甲基吡唑-1-基)吡啶 、 Fe4Cl8(THF)6 以 甲苯 为溶剂， 以90%的产率得到2,6-bis(3,5-dimethylpyrazoyl)pyridine iron(II) chloride
  参考文献：
  名称：

  Synthesis and structural characterization of iron(II) derivatives of heterocyclic tridentate amines

  摘要：

  Compounds of general formula FeX2(L) {L=2,6-bis(3,5-dimethyl-N-pyrazolyl)pyridine, C15H17N5; bis[3,5-dimethyl-N-pyrazolyl)methyl]-isopropylamine, C15H25N5; bis(benzimidazol-2-yl-methyl)amine, C16H15N5, 1,3-bis(benzimidazolyl)propane, C17H16N4; bis(benzimidazolyl-2-methyl)ether, C16H14N4O; bis(benzimidazolyl-2-methyl)thioether, C16H14N4S} have been synthesized by reacting the amine with Fe4Cl8(THF)(6) or FeI2(CO)(4) in toluene. The complexes FeCl2(Cl15H17N5).MeCN and FeCl2(C16H15N5)(MeOH) have been characterized by single crystal X-ray diffraction together with the parent triamines, C15H17N5 and C16H15N5, for comparison. The reaction of FeI2(CO)(4) with bis(benzimidazolyl-2-methyl)thioether, C16H14N4S, led to the product of partial carbonyl substitution Fel(2)(CO)(2)(C16H14N4S). (C) 2002 Elsevier Science B.V. All rights reserved.

  DOI：

  10.1016/s0020-1693(02)01304-x
• 作为试剂：
  描述：

  邻氯苯乙酮 在 2,6-bis(3,5-dimethylpyrazoyl)pyridine iron(II) chloride 、 potassium hydroxide 作用下， 以 异丙醇 为溶剂， 反应 48.0h， 生成 1-(2-氯苯基)乙醇
  参考文献：
  名称：

  （吡唑）吡啶铁（II）和镍（II）配合物介导的酮的转移加氢的结构，动力学和DFT研究

  摘要：

  一系列由2-吡唑基（甲基）吡啶（L1），2,6-双（吡唑基甲基）吡啶（L2）和2,6-双（吡唑基）吡啶（已经研究了L3）配体作为一系列酮的转移加氢（TH）催化剂。

  DOI：

  10.1039/c6ra12788f

文献信息

• Synthesis, characterization, and butadiene polymerization of iron(III), iron(II) and cobalt(II) chlorides bearing 2,6-bis(2-benzimidazolyl)pyridyl or 2,6-bis(pyrazol)pyridine ligand
  作者：Dirong Gong、Xiaoyu Jia、Baolin Wang、Xuequan Zhang、Liansheng Jiang

  DOI：10.1016/j.jorganchem.2011.11.025

  日期：2012.4

  and iron(II) (3c*DMF) complexes adopt a distorted octahedral configuration with the equatorial plane formed by the three nitrogen atoms and one chlorine atom, while the iron(II) (3a, 3b and 4a) and cobalt complexes (5a, 5b, 5c and 6c) adopt a trigonal bipyramidal configuration with the equatorial plane formed by the pyridyl nitrogen atoms and the two chlorine atoms. All complexes are evaluated as precursors

  带有中性N，N，N三齿配体的铁（III），铁（II）和钴（II）配合物（Fe（III）L1，1a ; Fe（III）L2，1b ; Fe（III）L3，1c ;的Fe（III）L4，图2a的Fe（III）L5，2B的Fe（III）L6，2C的Fe（II）L1，图3a的Fe（II）L2，3b中的Fe（II）L3，3c中的Fe（ II）L4，图4a的Fe（II）L5，4b中的Fe（II）L6，4C ; COL1，5A ; COL2，5B ; COL3，5C ; COL5，6B和COL6，图6c）已经从金属氯化物合成（的FeCl 3，的FeCL2 ·4H 2 O或CoCl 2），方法是处理相应的配体（2,6-双（苯并咪唑-2-基）吡啶，L1； 2,6-双（1'-乙基苯并咪唑-2'-基）吡啶，L2； 2,6-双（1'-苄基苯并咪唑-2'-基）吡啶L3； 2,6-双（吡唑）吡啶L4； 2,6-双（3-甲基吡唑）吡啶L5或2